RecruitingNot ApplicableNCT01929356

Chest Physiotherapy and Lung Function in Primary Ciliary Dyskinesia

The Influence of Chest Physiotherapy on Lung Function Parameters in Primary Ciliary Dyskinesia


Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

29 participants

Start Date

Jun 30, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

Primary ciliary dyskinesia (PCD) is a rare disease, caused by impairment of the motile cilia. Patients present with chronic upper and lower respiratory tract infections. The therapy is mainly supportive and based on that of cystic fibrosis. Chest physiotherapy is one of the cornerstones of the therapy, however the influence of chest physiotherapy on lung function (short term and long term) is not clear. For interpretation of longitudinal lung function data it is important to examine the short time effect of chest physiotherapy. We hypothesize that a session of chest physiotherapy improves lung function and that thus lung function tests must be performed in a standardized way.


Eligibility

Min Age: 6 YearsMax Age: 50 Years

Inclusion Criteria2

  • Primary ciliary dyskinesia
  • able to perform spirometry and MBW (>6 years)

Exclusion Criteria1

  • acute exacerbation

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREChest physiotherapy

20 minutes of chest physiotherapy by physiotherapist


Locations(1)

University Hospital Gasthuisberg Leuven

Leuven, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01929356


Related Trials